Skip to main content

New: Take the KSM™ AI Visibility Assessment and identify what is limiting your visibility in AI-generated answers. Start now

KSM™ Client Case Study

PeptideDoc: Building AI Visibility for a Physician-Led Medical Practice

From a 35/100 pre-launch KSM™ baseline, to 62/100 on Day 1, to 85/100 at Day 30.

PeptideDoc demonstrates how the Knowledge Structuring Model™ can be applied to a physician-led healthcare organization to improve how search engines and AI systems understand the organization, recognize physician authority, connect services and location, and find independent evidence that reinforces trust.

Pre-Launch

35/100

Day 1

62/100

Day 30

85/100

Improvement

+50 Points

Industry
Healthcare & Medical Services
Market
New York City & Tri-State Area
Physical Location
Bayside, Queens, New York
KSM™ Stage
Day 30 completed · Day 31–60 underway

01 · Starting point

The Challenge

PeptideDoc began with something many healthcare organizations already have: real physician expertise, an established medical practice, clinical services, and a physical location.

What it did not yet have was a consistently structured digital knowledge layer.

Search engines and AI systems had to interpret information distributed across webpages, physician profiles, service descriptions, business listings, directories, and external references.

The challenge was therefore not simply traditional SEO. The challenge was whether machines could clearly determine:

“What is PeptideDoc? Who owns and leads it? Where is care provided? What services does it offer? Which physician is responsible for care? And which external sources confirm that information?”

02 · Baseline

The Pre-Launch KSM™ Score

Structured Extractability

16/40

Entity Salience

14/40

Citation Authority

5/20

Total

35/100

The practice existed. The physician existed. The services existed. But the digital relationships between them were fragmented.

Structured Extractability
Can machines reliably retrieve and interpret the information?
Entity Salience
Can they correctly connect Dr. Saul F. Maslavi, PeptideDoc, the Bayside location, services, and credentials?
Citation Authority
Can external sources independently reinforce those relationships?

03 · Day 1 implementation

Making PeptideDoc Easier for Machines to Understand

The first implementation phase focused heavily on Structured Extractability and Entity Salience.

  • Canonical URL cleanup
  • Indexing directives
  • Structured service pages
  • JSON-LD
  • Breadcrumbs
  • FAQ structured data
  • Sitemap alignment
  • robots.txt
  • Physician identifiers
  • Practice identifiers
  • Service relationships
  • Location information
  • Contact pathways
  • Scheduling pathways
  • Consistent titles and descriptions
  • Physician-practice ownership language
  1. Saul F. Maslavi, MD
  2. Founder & Owner
  3. PeptideDoc
  4. Bayside, Queens
  5. Physician-Led Medical Care
Board certification
Family Medicine
Medical licensure (Dr. Maslavi)
New York and Florida
Physician NPI (Dr. Maslavi)
1134137383

04 · Day 1 result

The First Major Shift

Structured Extractability

30/40

Entity Salience

24/40

Citation Authority

8/20

Total

62/100

Improvement

+27 Points

The first phase demonstrated that PeptideDoc had become substantially easier for machines to interpret. The website was more structured. The physician relationship was clearer. The physical location and service relationships were more explicit.

But Day 1 also exposed the next constraint.

Day 1 evidence · External validation

Search Engine Validation

Bing Webmaster Tools was used as an external technical validation source for priority service pages.

Tirzepatide

Initial finding

Indexing allowed: No

After remediation

URL can be indexed by Bing

No SEO/GEO issues found

Medical Weight Management

Bing result

URL can be indexed by Bing

No SEO/GEO issues found

Peptide Therapy

Bing result

URL can be indexed by Bing

No SEO/GEO issues found

Tirzepatide was also aligned with the stronger structured-data architecture used by the other priority service pages.

Day 1 Remediation

10 strategic pages were standardized for:

  • Canonical URLs
  • Indexability
  • Titles
  • Descriptions
  • OpenGraph metadata
  • Organization identity
  • Physician identity
  • Founder/owner relationship
  • Physician NPI
  • Medical-service entities
  • Physical location
  • Breadcrumbs

Consistent entity IDs

https://peptidedoc.com/#clinic

https://peptidedoc.com/#dr-maslavi

Persistent IDs help machines understand that references across multiple pages describe the same clinic and the same physician.

Google Generative AI Visibility Enabled

On Day 1, PeptideDoc was explicitly configured in Google Search Console to allow its links and content to appear in Google's Search generative AI features, including AI Overviews and AI Mode.

This setting does not guarantee an AI citation. It ensures that PeptideDoc is not excluded from participation while KSM™ works to improve the structured, entity and authority signals that influence visibility.

05 · Day 1–30

Extending the Entity Beyond PeptideDoc.com

The Day 1–30 phase expanded the entity beyond the website.

  • Google Business Profile
  • Zocdoc
  • LinkedIn
  • Instagram
  • Healthcare directories
  • Professional physician profiles
  • External credential references
  • NPI identity alignment
  • Patient reviews and review pathways
  • Press coverage
  • Patient education
  • Booking pathways
  • Professional photography
  • External physician-practice-location links
“If PeptideDoc says something about itself, can independent sources say the same thing?”

That is the shift from owned information to corroborated information.

06 · Day 30 result

PeptideDoc Reaches 85/100

KSM™ pillar scores at Pre-Launch, Day 1 and Day 30.
PillarPre-LaunchDay 1Day 30
SEStructured Extractability16/4030/4036/40
ESEntity Salience14/4024/4034/40
CACitation Authority5/208/2015/20
Total35/10062/10085/100

+23 points from Day 1

+50 points from Pre-Launch

Healthcare study · Measured results

KSM™ Healthcare AI Visibility Study: Measured Results

Three measured checkpoints in PeptideDoc’s application of the Knowledge Structuring Model™. Day 60 and Day 90 remain future measurements.

Overall KSM™ Score Progression

On a 0–100 scale: Pre-Launch 35/100 → Day 1 62/100 (+27 points) → Day 30 85/100 (+50 total points).

  • Pre-Launch
  • Day 1
  • Day 30
Day 1: +27 pointsDay 30: +50 total points

Three-Pillar Performance

Grouped bars compare Pre-Launch, Day 1 and Day 30. Structured Extractability (SE) and Entity Salience (ES) each have a maximum of 40; Citation Authority (CA) has a maximum of 20. All values appear in the table below.

  • Pre-Launch
  • Day 1
  • Day 30
Measured pillar scores and overall totals. Each score includes its maximum.
PillarPre-LaunchDay 1Day 30
Structured Extractability (/40)16/4030/4036/40
Entity Salience (/40)14/4024/4034/40
Citation Authority (/20)5/208/2015/20
Total KSM™ score35/10062/10085/100

What the First 30 Days Reveal

Stage 1: A clearer owned knowledge layer

Pre-Launch to Day 1 brought a 27-point increase, from 35/100 to 62/100. Structured Extractability rose from 16/40 to 30/40 and Entity Salience from 14/40 to 24/40 as pages, structured data and physician-practice-location relationships became clearer. Citation Authority rose from 5/20 to 8/20 but remained the next constraint.

Stage 2: Stronger external corroboration

Day 1 to Day 30 added another 23 points, reaching 85/100 — 50 points above baseline. Structured Extractability reached 36/40, Entity Salience 34/40 and Citation Authority 15/20 as the entity expanded across external profiles, professional references, patient education and independent sources.

The key marketing finding

The constraint shifted from digital structure toward topical authority and independent corroboration. The next opportunity is not simply more pages: it is stronger answers to real patient questions and independent evidence reinforcing the same physician-practice relationships.

These KSM™ scores describe the measured knowledge, entity and authority signals. They do not measure actual AI recommendations or patient acquisition, and do not establish those outcomes. Day 60 and Day 90 results have not yet been measured.

07 · What changed

From Structure to Recognition

  1. Pre-Launch

    Can AI understand the organization?

  2. Day 1

    Can AI recognize the organization and connect the right entities?

  3. Day 30

    Can AI find enough independent evidence to trust and corroborate those entities?

Structured Extractability → Entity Salience → Citation Authority

Understand → Recognize → Trust

08 · Citation Authority

The Most Important Day 30 Development

The website itself was no longer the main limitation. The larger opportunity became the external authority network around PeptideDoc.

That network includes healthcare profiles, physician directories, Zocdoc, Google Business Profile, professional platforms, media coverage, external credential sources, and other references connecting PeptideDoc with Dr. Maslavi and the Bayside practice.

Once AI can understand and correctly recognize a healthcare organization, does independent external corroboration become the primary constraint on whether that organization is trusted, surfaced, and cited?

Pre-Launch

5/20

Day 1

8/20

Day 30

15/20

Citation Authority

09 · Patient education

Building Topical Authority Around Real Patient Questions

The Day 1–30 phase also introduced a stronger patient-education layer. Rather than building content around generic peptide keywords alone, PeptideDoc began addressing the questions patients may ask before choosing a provider.

  • Physician oversight
  • Treatment eligibility
  • Laboratory testing
  • FDA-approved versus compounded medications
  • Monitoring
  • Safety
  • Medical decision-making
  • Questions patients should ask before choosing a provider

10 · Day 30 finding

The Constraint Changed Again

At the start of the case study, the primary constraint was digital structure. By Day 1, the owned knowledge layer had improved substantially. By Day 30, entity recognition and external corroboration had become much stronger.

The next bottleneck is: Topical Authority + Independent Citation Authority

The organization no longer simply needs more pages. It needs stronger answers to real patient questions and more independent sources that reinforce the same physician-practice relationships.

11 · Day 31–60

The Next Phase

The Day 31–60 phase will focus on expanding topical authority while continuing to strengthen independent corroboration.

  • Patient-question content
  • Physician-led clinical education
  • Laboratory-testing education
  • Treatment eligibility
  • Medication-status education
  • Monitoring and follow-up
  • Physician oversight
  • Healthcare directory consistency
  • Additional external citations
  • Branded AI query monitoring
  • Non-branded AI query monitoring
  • Citation testing
  • Google and Bing recognition
  • AI answer visibility

First Day 31–60 Content Topic

Do You Need Lab Work Before Peptide Therapy?

Planned next content topic. The article has not been created as part of this update.

12 · 90-day progression

PeptideDoc KSM™ Journey

  1. Pre-Launch

    35/100

    Fragmented structure and limited external authority.

  2. Day 1

    62/100

    The owned digital knowledge layer became substantially more machine-readable.

  3. Day 30

    85/100

    Entity relationships strengthened across external platforms and Citation Authority grew significantly.

  4. Day 60

    Next Measurement

    Focus: topical authority, corroboration, and AI recognition.

  5. Day 90

    Final Measurement

    Focus: whether the combined implementation produces sustained improvements across the three KSM™ pillars.

The 90-day audit at a glance

The infographic below summarizes the measured checkpoints above alongside the pillar-level detail behind them.

Infographic: PeptideDoc KSM™ 90-Day Audit. A five-stage timeline shows Pre-Launch 35/100, Day 1 62/100 and Day 30 85/100, with Day 60 as the next measurement and Day 90 as the final measurement. Bar charts and a scores table give each KSM™ pillar at each stage, and three panels list Day 30 visibility highlights, Day 30 key takeaways, and the Day 60 and Day 90 next steps. Every figure in the graphic is repeated in the text summary directly below.
PeptideDoc KSM™ 90-day audit overview. Day 60 and Day 90 measurements have not yet been scored. A full text summary of the figures appears directly below.

Text summary of the 90-day audit

PeptideDoc's overall KSM™ score rose from 35/100 at Pre-Launch to 62/100 on Day 1, a gain of 27 points, and to 85/100 at Day 30 — a further 23 points, and 50 points above the Pre-Launch baseline. Day 60 is the next measurement and Day 90 the final measurement; neither has been scored yet.

KSM™ pillar scores by stage, as shown in the 90-day audit infographic.
KSM™ pillar (weight)Pre-LaunchDay 1Day 30
SEStructured Extractability (40%)16/4030/4036/40
ESEntity Salience (40%)14/4024/4034/40
CACitation Authority (20%)5/208/2015/20
Total KSM™ score35/10062/10085/100
Visibility highlights (Day 30)
  • Stronger digital knowledge foundation, including structured pages, FAQs and patient guides.
  • More consistent entity recognition across the physician, practice, location and services.
  • Greater external authority through verified profiles, professional references and broader corroboration.
Key takeaways (Day 30)
  • +50 points overall, from 35/100 to 85/100.
  • Strong gains in all three KSM™ pillars.
  • From basic readiness to a high-visibility foundation for continued growth.

Next steps shown in the graphic: Day 60 will measure topical authority, corroboration and AI recognition. Day 90 is the final measurement of whether the combined implementation produces sustained improvements across the three KSM™ pillars.

Research Question

Once AI can understand and correctly recognize a healthcare organization, does independent external corroboration become the primary constraint on whether that organization is trusted, surfaced, and cited?

PeptideDoc provides a real-world healthcare environment for testing that question over time.

Next step

What Would AI Systems Understand About Your Organization?

PeptideDoc is the first paid client deployment in the KSM™ Multi-Vertical SMB AI Visibility Study.